Clinical Trial Update: Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin plus docetaxel with day 2 pegfilgrastim (Neulasta) in advanced ovarian carcinoma was terminated; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-08-19